Brain Activity Associated With Inhibition of Action in Attention-deficit

Launched by UNIVERSITY HOSPITAL, TOULOUSE · Feb 23, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how the brain works when people with Attention Deficit Hyperactivity Disorder (ADHD) try to control their actions and ignore distractions. Researchers want to understand the challenges that adults with ADHD face in stopping unwanted behaviors and focusing on what’s important. To do this, they will look at brain activity and compare adults with ADHD to two other groups: one group of people who have had similar concerns but do not have ADHD, and another group of healthy volunteers.

To participate in this study, you need to be between the ages of 18 and 50, be right-handed, and have the ability to complete certain tests. If you have been diagnosed with ADHD based on specific guidelines, you may join the ADHD group. If you’ve also sought help for cognitive issues but were not diagnosed with ADHD, you might qualify for the control group. All participants will need to provide written consent and be able to communicate in French. This study is currently looking for volunteers, and participation will involve undergoing various tests to help researchers learn more about ADHD and its effects on the brain.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age between 18 and 50,
• • Visual, auditory (authorized apparatus), motor skills suitable for the proper realization of neuropsychological tests,
• • Being right-handed,
• • Free, informed and written consent signed by the participant and the investigator
• • Person affiliated or beneficiary of a social security scheme.
• * For the ADHD group:
• • Diagnosis of ADHD according to DSM-V criteria (APA, 2013),
• For the patient control group:
• • • Patient who consulted for a cognitive complaint and for whom the diagnosis of ADHD was rejected according to the criteria of DSM-V (APA, 2013).
• Exclusion Criteria:
• • General or progressive neurological disease resulting in cognitive impairment (multiple sclerosis, Parkinson's disease, stroke, etc.),
• • Insufficient linguistic level in French to participate in neuropsychological assessment,
• • Patient placed under judicial protection or under another protective regime,
• • Severe depression according to DSM-V criteria (APA, 2013),
• • Autism spectrum disorder, developmental coordination disorder.
• -For the healthy voluntary control group:
• • Presence of a cognitive complaint or pathology which may impair his cognitive functions